Management of immune-related adverse events: A single-center retrospective analysis in a real-world scenario.

被引：0
|
作者：
Iacono, Donatella
Vitale, Maria Grazia
Cortiula, Francesco
Macerelli, Marianna
Cinausero, Marika
Minisini, Alessandro Marco
Valent, Francesca
Tullio, Annarita
Palmero, Lorenza
Targato, Giada
Zara, Diego
Fasola, Gianpiero
机构：
[1] Univ Hosp Udine, Dept Oncol, Udine, Italy
[2] Univ Udine, Dept Med DAME, Udine, Italy
[3] Azienda Sanit Univ Integrata Udine, Dipartimento Oncol, Udine, Italy
[4] Univ Hosp Udine, Inst Hyg & Clin Epidemiol, Udine, Italy
[5] Univ Udine, Udine, Italy
[6] Univ Hosp Udine Santa Maria della Misericordia, Dept Oncol, Udine, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15163
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world management of immune-related adverse events in the community setting
    Johnson, D. B.
    Bruno, D.
    Rioth, M.
    Zhang, C.
    Palaia, J.
    Pisupati, R.
    Bond, C.
    Rosenblatt, L. C.
    Broome, R. G.
    Teka, M.
    Kluger, H.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1268 - S1269
  • [2] Real-World Adherence to Toxicity Management Guidelines for Immune-Related Adverse Events
    Teimouri, Arezou
    Minard, Laura, V
    Scott, Samantha N.
    Daniels, Amanda
    Snow, Stephanie
    CURRENT ONCOLOGY, 2022, 29 (05) : 3104 - 3117
  • [3] Real-World Incidence and Management of Immune-Related Adverse Events from Immune Checkpoint Inhibitors: Retrospective Claims-Based Analysis
    Brown, Victoria T.
    Antol, Dana Drzayich
    Racsa, Patrick N.
    Ward, Melea A.
    Naidoo, Jarushka
    CANCER INVESTIGATION, 2021, 39 (10) : 789 - 796
  • [4] Defining real-world criteria for immune-related adverse events (irAEs).
    Singh, Prabhsimranjot
    Brito, Amanda
    Abdulnour, Raja-Elie E.
    Grover, Shilpa
    Yenulevich, Eric
    Stuver, Sherri Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study
    Kuusisalo, Saara
    Koivunen, Jussi P.
    Iivanainen, Sanna
    CANCERS, 2022, 14 (09)
  • [6] Real-world incidence and outcomes of immune-related adverse events in NSCLC patients
    Knox, A.
    Cloney, T.
    Janssen, H.
    Solomon, B.
    Alexander, M.
    John, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S1684 - S1684
  • [7] Acknowledging and addressing real-world challenges to treating immune-related adverse events
    von Itzstein, Mitchell S.
    Gerber, David E.
    Bermas, Bonnie L.
    Meara, Alexa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07)
  • [8] Real-world characterization of patients with cancer admitted with immune-related adverse events (irAEs).
    Eng, Lawson
    Chen, RuiQui
    Smith, Elliot Charles
    Chan, Sze Wah Samuel
    Hueniken, Katrina
    Brown, M. Catherine
    Majeed, Habeeb
    Ross, Kendra
    Gray, Diana
    Xu, Wei
    Hogg, David
    Sridhar, Srikala S.
    Sacher, Adrian G.
    Leighl, Natasha B.
    Krzyzanowska, Monika K.
    Liu, Geoffrey
    Butler, Marcus O.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [9] Immune-related adverse events in cancer patients treated with immune checkpoint inhibitors A single-center experience
    Kaur, Aneet
    Doberstein, Taylor
    Amberker, Rachana Ramesh
    Garje, Rohan
    Field, Elizabeth Hirak
    Singh, Namrata
    MEDICINE, 2019, 98 (41)
  • [10] Delayed immune-related adverse events in long-responders of immunotherapy: a single-center experience
    Kitano, Masatake
    Honda, Takayuki
    Hikita, Eri
    Masuo, Masahiro
    Miyazaki, Yasunari
    Kobayashi, Masayoshi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (04) : 463 - 471
12345